Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The β‐adrenergic hypothesis of synaptic and microglial impairment in Alzheimer's disease
Shaomin Li
Journal of Neurochemistry (2023) Vol. 165, Iss. 3, pp. 289-302
Open Access | Times Cited: 12

Showing 12 citing articles:

Relationship between enriched environment and neurodegeneration: a review from mechanism to therapy
Yang Xu, YangQuan Chen, Jia‐xin Xing, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Evidence from a mouse model supports repurposing an anti-asthmatic drug, bambuterol, against Alzheimer’s disease by administration through an intranasal route
Anne‐Claire Groo, Thomas Curel, Aurélie Malzert‐Freon, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Drug repurposing for neurodegenerative diseases using Zebrafish behavioral profiles
Thaís Del Rosario Hernández, Sayali V. Gore, Jill A. Kreiling, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116096-116096
Open Access | Times Cited: 5
Deciphering the Role of Adrenergic Receptors in Alzheimer’s Disease: Paving the Way for Innovative Therapies
Αndroulla N. Miliotou, Andria Kotsoni, Lefteris C. Zacharia
Biomolecules (2025) Vol. 15, Iss. 1, pp. 128-128
Open Access
The lateralized LC-NAergic system distinguishes vicarious versus direct fear in mice
Jong–Hyun Kim, Dennis C. Choi, Hee‐Sup Shin
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Implication of Central β2 Adrenergic Receptor for the Development of Novel Drugs Against Alzheimer's Disease
A. Wang, Marc Since, Patrick Dallemagne, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 4
Open Access
Periodontal disease and risk of Alzheimer's disease: A two‐sample Mendelian randomization
Conglei Hu, Hui Li, Liping Huang, et al.
Brain and Behavior (2024) Vol. 14, Iss. 4
Open Access | Times Cited: 3
Combined in vivo MRI assessment of locus coeruleus and nucleus basalis of Meynert integrity in amnestic Alzheimer’s disease, suspected-LATE and frontotemporal dementia
Julien Lagarde, Pauline Olivieri, Mattéo Tonietto, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Recent advancements in the therapeutic approaches for Alzheimer's disease treatment: Current and future perspective
Amit Sharma, Santosh Rudrawar, Sandip B. Bharate, et al.
RSC Medicinal Chemistry (2024)
Open Access | Times Cited: 2
Confounding in observational studies evaluating the association between Alzheimer's disease and periodontal disease: A systematic review
Gustavo G. Nascimento, Fábio Renato Manzolli Leite, Caio Melo Mesquita, et al.
Heliyon (2023) Vol. 9, Iss. 4, pp. e15402-e15402
Open Access | Times Cited: 6
One-Trial Appetitive Learning Tasks for Drug Targeting
Robert Lalonde, C. Strazielle
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 6, pp. 680-686
Closed Access
Finding Drug Repurposing Candidates for Neurodegenerative Diseases using Zebrafish Behavioral Profiles
Thaís Del Rosario Hernández, Sayali V. Gore, Jill A. Kreiling, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top